Life Sciences BG | IDH1 and IDH2 mutations in myeloid neoplasms - Novel paradigms and clinical implications

IDH1 and IDH2 mutations in myeloid neoplasms - Novel paradigms and clinical implications

(No abstract is available for this citation)

Read the original article at Haematologica.

Published: Oct 2010, Updated: 9th Oct

Most recent items in "Хематология":

9th Oct Хематология: Generation of mature blood cells from pluripotent stem cells

(No abstract is available for this citation)

Read the original article at Haematologica....

9th Oct Хематология: CD30+ lymphoproliferative disorders

(No abstract is available for this citation)

Read the original article at Haematologica....

9th Oct Хематология: Prophylaxis of invasive fungal diseases in patients with hematologic disorders

(No abstract is available for this citation)

Read the original article at Haematologica....

9th Oct Хематология: Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation

Background

Ets-1 is a widely expressed transcription factor implicated in several biological processes including hematopoiesis, where it contributes to the regulation of cellular differentiation. The functions of Ets-1 are regulated by transcription factors as well as by phosphorylation e...

9th Oct Хематология: Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesis

Background

Cdx4 is a homeobox gene essential for normal blood formation during embryonic development in the zebrafish, through activation of posterior Hox genes. However, its role in adult mammalian hematopoiesis has not been extensively studied and its requirement in leukemia associated ...